Erdafitinib is a inhibitor for urothelial carcinoma that has FGFR2/3 changes. You can get it in tablets that are 3, 4, or 5 milligrams, all with a film coating. The usual dose is 8 milligrams a day, but it can go up to 9 if needed.
The stuff comes in bottles with 56 tablets in each. The main thing in this stuff blocks something called FGFR signaling, which is linked to changes in the FGFR2 and FGFR3 genes. The tablets are meant to be taken by mouth, and they have that film coating to make them easier to swallow.
The way it’s made makes sure the medicine comes out evenly so it works as well as it can.
